A significant effort is underway to develop new antimicrobial compounds for both food and pharmaceutical industry. Bacteriocins are peptides produced by a number of bacteria that harbor bacteriostatic or bactericide effect over pathogenic and deleterious microorganism present in industrial processes. The ones produced by lactic acid bacteria (LABs) present an interest on industry as some of them are probiotic, therefore, acknowledged as safe on this field. In this context, the aim of this project is the maximization of pediocin A production by Pediococcus pentosaceus ATCC 43200 probiotic bacterium through molecular biology tools combined with techniques of scale up improvement on fermentation process. The first step of this project consists in the identification pediocin A gene from P. pentosaceus ATCC43200 and the physical chemical characterization of this bacteriocin. Secondly, the construction of a recombinant strain of P. pentosaceus ATCC 43200 over-expressing heterologously the induction factor and subsequently the comparison of its pediocin productivity with the corresponding wild type via qPCR in order to quantify pediocin transcripts. Finally, we intend to evaluate the effect of different parameters on pediocin A productivity in the recombinant strain of P. pentosaceus ATCC 43200. For this purpose, the experiments will be carry out using fractional factorial designs and/or rotational central composite design (RCCD). The results obtained will lead to establish the scale up parameters, starting from small scale assays followed by 3L discontinuous bioreactor.
News published in Agência FAPESP Newsletter about the scholarship: